Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$25.89 - $33.45 $517,800 - $669,000
-20,000 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$22.46 - $29.47 $3.24 Million - $4.25 Million
-144,312 Reduced 87.83%
20,000 $551,000
Q2 2021

Aug 16, 2021

BUY
$24.17 - $36.01 $3.97 Million - $5.92 Million
164,312 New
164,312 $4.68 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Ghisallo Capital Management LLC Portfolio

Follow Ghisallo Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghisallo Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghisallo Capital Management LLC with notifications on news.